Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
81 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2022
82 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
83 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
84 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Department of Clinical Pathology Dr. Noha gaber sayed 2022
85 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022
86 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Samar Muhammad mansour 2022
87 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Dr. Shimaa Hassan Shabaan Hassan 2022
88 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
89 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Heba Mohamed Sayed Mahmoud Al-Masry 2022
90 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021